IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.

MLA

Wang, Na, et al. “IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.” Acta Haematologica, vol. 138, no. 3, Nov. 2017, pp. 143–51. EBSCOhost, https://doi.org/10.1159/000479546.

APA

Wang, N., Wang, F., Shan, N., Sui, X., & Xu, H. (2017). IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes. Acta Haematologica, 138(3), 143–151. https://doi.org/10.1159/000479546

Chicago

Wang, Na, Fei Wang, Ningning Shan, Xiaohui Sui, and Hongzhi Xu. 2017. “IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.” Acta Haematologica 138 (3): 143–51. doi:10.1159/000479546.